Evidence map›Paper›PMID 41922617›Full record

ArticleMolecular neurobiology2026

Cuproptosis Inhibition by C-Phycocyanin Confers Neuroprotection against Copper-Induced Mitochondrial Damage and Cognitive Impairment.

Run Song, Junwan Fan, Jiannan Wu, Shiyi Yin, Ying Zhang, Shihe Jiang, Yan Li, Xin Zhao, Mengjiao Sun, Weina Jin and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Run Song *Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Junwan Fan *Center for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiannan WuNeuromolecular Biology Laboratory, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471003, China.
Shiyi YinGuangdong Province Key Laboratory of Brain Function and Disease, Department of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, #74, Zhongshan 2(Nd) Road, Guangzhou, 510080, Guangdong, China.
Ying ZhangCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shihe JiangCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yan LiCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xin ZhaoDepartment of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Mengjiao SunCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Weina JinCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wenyan HeCenter for Neurological Diseases, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. hewenyan77@163.com.
Junqiang YanDepartment of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China. yanjq20062007@126.com.

Funding

Henan Province's Project for Cultivating Middle-aged and Young Health Science and Technology Innovation Talents LJRC2025019
6 · The paper itself

Abstract

Copper (Cu) is an essential trace element, but its dyshomeostasis has been increasingly linked to neurotoxicity and neurodegenerative diseases. The specific contribution of cuproptosis, a novel copper-dependent regulated cell death pathway, to neuronal damage remains poorly defined. This study evaluated the neuroprotective potential of C-phycocyanin (C-PC), a natural compound derived from Spirulina, against Cu-induced neurotoxicity, with a focus on cuproptosis. In vitro, C-PC treatment markedly attenuated Cu-induced cell death in mouse neuronal cells. It restored mitochondrial membrane potential, ameliorated oxidative stress by reducing malondialdehyde (MDA) and elevating adenosine triphosphate (ATP) levels, and restored key cuproptosis markers, including FDX1 and lipoylated DLAT. In Cu-exposed mice, oral administration of C-PC ameliorated cognitive deficits, as assessed by the Morris water maze test, and reduced neuronal loss in the hippocampus. Biochemical analysis of brain tissue further confirmed that C-PC mitigated oxidative damage and suppressed the expression of cuproptosis-related proteins. These results indicate that C-PC is a potent inhibitor of cuproptosis, exerting its effects primarily by preserving mitochondrial integrity and reducing proteotoxic stress. Given its biocompatibility and natural origin, C-PC represents a promising therapeutic candidate for countering Cu-induced neurotoxicity.

Indexed as

Cognitive DysfunctionCopperCuproptosisMitochondriaNeuroprotectionNeuroprotective AgentsPhycocyaninAnimalsCell DeathHippocampusMaleMembrane Potential, MitochondrialMiceMice, Inbred C57BLNeuronsOxidative StressCopperNeuroprotective AgentsPhycocyaninCognitive functionCopper neurotoxicityC-PhycocyaninCuproptosisOxidative stress

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.